Security key
37611X100
RECURSION PHARMACEUTICALS INC - COMMON STOCK (DNA)
CUSIP: 37611X100
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 1,138,832,894
- Total 13F value
- $1,513,754,471
- Share change
- +144,204,497
- Put/Call ratio
- 123%
- SEC-reported price per share
- $1.33
- Number of holders
- 308
- Value change
- +$188,812,259
- Number of buys
- 141
- Number of sells
- 122
- Shares outstanding
- 518,011,600
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
308
Top holders
10
DNA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
RECURSION PHARMACEUTICALS, INC. SEC filings
RECURSION PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 37611X100
Recent filing periods:
Ownership snapshot
Top reported holders of DNA - RECURSION PHARMACEUTICALS INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Anchorage Capital Group, ...
Disclosed value leader
Anchorage Capital Group, ...
Comparable rows
15/15
Latest evidence
31 Dec 2022
13F
Lead comparable stake: 13%
Showing 1-6 of 15 holder rows.
Quick read
Anchorage Capital Group, L.L.C. leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Anchorage Capital Group, L.L.C.'s linked filing trail.
Comparable ownership
Top 5
Anchorage Capital Group, L.L.C.
13%
VIKING GLOBAL INVESTORS LP
12%
GENERAL ATLANTIC, L.P.
6.2%
SB INVESTMENT ADVISERS (UK) LTD
4.7%
MIC Capital Management UK LLP
1.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Anchorage Capital Group, L.L.C. |
13F
Company
|
13%
|
$118,054,262
69,854,593 shares
|
— | 31 Dec 2022 |
| VIKING GLOBAL INVESTORS LP |
13F
Company
|
12%
|
$106,613,863
63,085,126 shares
|
— | 31 Dec 2022 |
| GENERAL ATLANTIC, L.P. |
13F
Company
|
6.2%
|
$54,620,624
32,319,896 shares
|
— | 31 Dec 2022 |
| SB INVESTMENT ADVISERS (UK) LTD |
13F
Company
|
4.7%
|
$41,285,333
24,429,191 shares
|
— | 31 Dec 2022 |
| MIC Capital Management UK LLP |
13F
Company
|
1.6%
|
$65,163,057
8,451,758 shares
|
— | 31 Dec 2022 |
| Kinnevik AB (publ) |
13F
Company
|
1.5%
|
$59,005,100
7,653,061 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
308
Shares
1,138,832,894
Rows available
308
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q1 2023 Across Filers
Q1 2023 holders
308
Q1 2023 holders
308
Holder diff
0
| Investor | Q1 2023 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q1 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend